Pathophysiology of Metabolic Diseases

Diabetes and obesity (metabolic diseases) are two major epidemics of the 21st century that constitute a major public health concern worldwide. The study of their pathophysiology can contribute to generate the novel knowledge for searching new treatments and therapies to counteract the impact of these chronic non-communicable diseases in patients. Our group focuses on the following general objectives: 1) Study of the physiology and pathophysiology of hormone secretion (insulin, glucagon, somatostatin) of the pancreas. 2) Physiology and pathophysiology of glucose homeostasis and insulin resistance in liver and skeletal muscle. 3) Physiology and pathophysiology of plasma insulin clearance. Translated with www.DeepL.com/Translator (free version)